Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cheetham

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primatesMatthew J Hansard, Lance A Smith, Michael J Jackson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 29, 2000
Effect of aerobic and resistance exercise training on vascular function in heart failureA Maiorana, G O'Driscoll, L Dembo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 27, 2004
The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primatesMatthew J Hansard, Lance A Smith, Michael J Jackson, et al.
Handbook of Experimental Pharmacology|November 7, 2012
Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesityDavid J Heal, Jane Gosden, Helen C Jackson, et al.
Psychopharmacology|January 1, 1991
Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatmentF De Paermentier, S C Cheetham, M R Crompton, et al.
Journal of Affective Disorders|January 1, 1990
Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victimsG M Stocks, S C Cheetham, M R Crompton, et al.
Brain Research|August 13, 1990
Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victimsF De Paermentier, S C Cheetham, M R Crompton, et al.
British Journal of Pharmacology|December 1, 1989
Lower cortical beta-adrenoceptor binding sites in post-mortem samples from depressed suicide victimsF De Paermentier, S C Cheetham, M R Crompton, et al.
Neuropharmacology|August 1, 1993
[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatmentsS C Cheetham, J A Viggers, N A Slater, et al.
Neuropharmacology|January 1, 1996
[3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatmentsS C Cheetham, J A Viggers, S A Butler, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primatesMatthew J Hansard, Lance A Smith, Michael J Jackson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 29, 2000
Effect of aerobic and resistance exercise training on vascular function in heart failureA Maiorana, G O'Driscoll, L Dembo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 27, 2004
The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primatesMatthew J Hansard, Lance A Smith, Michael J Jackson, et al.
Handbook of Experimental Pharmacology|November 7, 2012
Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesityDavid J Heal, Jane Gosden, Helen C Jackson, et al.
Psychopharmacology|January 1, 1991
Brain beta-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatmentF De Paermentier, S C Cheetham, M R Crompton, et al.
Journal of Affective Disorders|January 1, 1990
Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victimsG M Stocks, S C Cheetham, M R Crompton, et al.
Brain Research|August 13, 1990
Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victimsF De Paermentier, S C Cheetham, M R Crompton, et al.
British Journal of Pharmacology|December 1, 1989
Lower cortical beta-adrenoceptor binding sites in post-mortem samples from depressed suicide victimsF De Paermentier, S C Cheetham, M R Crompton, et al.
Neuropharmacology|August 1, 1993
[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatmentsS C Cheetham, J A Viggers, N A Slater, et al.
Neuropharmacology|January 1, 1996
[3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatmentsS C Cheetham, J A Viggers, S A Butler, et al.
Pageof 10